Stock listing

CLYM Stock Price, News, Filings & Events — Climb Bio, Inc.

Selected listing: CLYM · BOATS · USD · US

This page tracks Climb Bio, Inc.'s CLYM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CLYM:BOATS. CLYM:BOATS is the stock-level entry point for investors researching Climb Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Climb Bio, Inc. (ticker: CLYM) is a public company based in America with a market capitalization of approximately $735.26 million. The company focuses on biotechnology and aims to develop innovative solutions in its field. Climb Bio is committed to advancing its research and development efforts to contribute to the healthcare industry.

CLYM:BOATSUSDUSUpdated September 11, 2026
Climb Bio, Inc. logo
Ticker
CLYM:BOATS
Asset type
Stock
Market cap
$818.5M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Climb Bio, Inc. CLYM:BOATS stock context

This page tracks Climb Bio, Inc.'s CLYM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CLYM:BOATS. CLYM:BOATS is the stock-level entry point for investors researching Climb Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Climb Bio, Inc. (ticker: CLYM) is a public company based in America with a market capitalization of approximately $735.26 million. The company focuses on biotechnology and aims to develop innovative solutions in its field. Climb Bio is committed to advancing its research and development efforts to contribute to the healthcare industry.

Latest news from Climb Bio, Inc.

All Climb Bio, Inc. news →

Research Climb Bio, Inc.

Alternate listings